








As-tu entendu dire que les médicaments GLP-1, comme l’Ozempic, pourraient améliorer la fertilité chez certaines personnes?
Bien qu’ils puissent s’avérer utiles pour certaines personnes, il n’existe pas suffisamment de données pour affirmer que les agonistes des récepteurs du GLP-1 sont bénéfiques ou sécuritaires pour tout le monde.
Collab avec @PWHRCanada.
Sources
- How glucagon-like peptide 1 receptor agonists work | Endocrine COnnections | June 2021
- Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy – Nature | September 2024
- A Systematic Review on GLP-1 Receptor Agonists in Reproductive Health: Integrating IVF Data, Ovarian Physiology and Molecular Mechanisms | International Journal of Molecular Sciences – MDPI | January 2026
- The effects of glucagon-like peptide-1 receptor agonists on fertility, contraception, and pregnancy: clinical perspectives | The European Journal of Contraception & Reproductive Health Care | December 2025
- Effect of GLP1 Agonists on Reproduction | The Journal of Clinical Endocrinology & Metabolism – Oxford Academic | July 2025
- GLP-1 Receptor Agonists in Reproductive Medicine: A Narrative Review and Investigational Pilot Survey of Patient Perspectives in Academic Reproductive Endocrinology | Reproductive Sciences – Springer Nature Link | June 2026
- Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence | Frontiers in Endocrinology | October 2023
- Glucagon-like peptide-1 receptor agonists during pregnancy and lactation | CMAJ | December 2024
- GLP-1 use during early pregnancy may not increase risk of major adverse outcomes | Harvard T.H. Chan | June 2026
- Continuing Glucagon-Like Peptide-1 Receptor Agonists Into the First Trimester of Pregnancy and Pregnancy Outcomes: A Target Trial Emulation Study Using Claims Information | Annals of Internal Medicine | June 2026
- Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services | BJM Open | April 2024
- Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review | Reproductive Biology and Endocrinology | January 2025
- Le PMOS et les GLP-1s | LaSciencedAbord | Octobre 2026
Partagez notre post original de Bluesky !
Voir notre post Instagram original !
